Study of the association between growth differentiation factor 15 gene polymorphism and coronary artery disease in a Chinese population

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5085-5091

  Chen, Zhong ^a   Xie, Fangyi ^b   Ma, Genshan ^a   Feng, Yi ^a   Qian, Qi ^a   Liu, Naifeng ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Coronary artery disease; Genetics; Growth differentiation factor 15; Polymorphism; Single nucleotide

Indexed keywords

CYSTEINE; GLYCINE;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GROWTH DIFFERENTIATION FACTOR 15 GENE; HEART INFARCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 84855213677     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0655-4     Document Type: Article

References (33)

1. He J, Gu D, Wu X et al (2005) Major causes of death among men and women in China. N Engl J Med 353:1124-1134 (Pubitemid 41317435)
2. Wilson PW, D'Agostino RB, Levy D et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847 (Pubitemid 28213628)
3. Zdravkovic S, Wienke A, Pedersen NL et al (2002) Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 252:247-254
4. McPherson R, Pertsemlidis A, Kavaslar N et al (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488-1491 (Pubitemid 46906617)
5. Samani NJ, Erdmann J, Hall AS et al (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357:443-453 (Pubitemid 47204873)
6. Chen Z, Yin QZ, Ma GS et al (2009) Myeloperoxidase gene-463GA polymorphism and premature coronary artery disease. Genet Mol Biol 32:260-263
7. Wang LS, Yan JJ, Tang NP et al (2010) A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease. Mol Biol Rep 38(2):819-825
8. Chen Z, Qian Q, Ma G et al (2009) A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease. Mol Biol Rep 36:889-893
9. Karaali ZE, Sozen S, Yurdum M et al (2010) Effect of genetic variants of chemokine receptors on the development of myocar-dial infarction in Turkish population. Mol Biol Rep 37:3615-3619
10. Chen Z, Zhang X, Ma G et al (2010) Association study of four variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery disease in a Chinese population. Mol Biol Rep 37:207-212
11. Bootcov MR, Bauskin AR, Valenzuela SM et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94:11514-11519 (Pubitemid 27451030)
12. Kempf T, Eden M, Strelau J et al (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98:351-360
13. Xu J, Kimball TR, Lorenz JN et al (2006) GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342-350
14. Heger J, Schiegnitz E, von Waldthausen D et al (2010) Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes. J Cell Physiol 224:120-126
15. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
16. Brown DA, Breit SN, Buring J et al (2002) Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359:2159-2163 (Pubitemid 34694024)
17. Kempf T, Björklund E, Olofsson S et al (2007) Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J 28:2858-2865 (Pubitemid 350233034)
18. Khan SQ, Ng K, Dhillon O et al (2009) Growth differentiation factor-15 as a prognostic marker in patients with acute myocar-dial infarction. Eur Heart J 30:1057-1065
19. Wollert KC, Kempf T, Peter T et al (2007) Prognostic value of growth-differentiation factor-15 in patients with non-ST-eleva-tion acute coronary syndrome. Circulation 115:962-971 (Pubitemid 46328289)
20. Eggers KM, Kempf T, Lagerqvist B et al (2010) Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome. Circ Cardiovasc Genet 3:88-96
21. Kempf T, von Haehling S, Peter T et al (2007) Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50:1054-1060 (Pubitemid 47348231)
22. Taddei S, Virdis A (2010) Growth differentiation factor-15 and cardiovascular dysfunction and disease: malefactor or innocent bystander? Eur Heart J 31:1168-1171
23. Wang X, Yang X, Sun K et al (2009) The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. Clin Sci 118:137-145
24. Favis R, Day JP, Gerry NP et al (2000) Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 18:561-564 (Pubitemid 30313972)
25. Xiao Z, Xiao J, Jiang Y et al (2006) A novel method based on ligase detection reaction for low abundant YIDD mutant detection in hepatitis B virus. Hepatol Res 34:150-155
26. Anker SD, Doehner W, Rauchhaus M et al (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107:1991-1997 (Pubitemid 36506072)
27. Baek SJ, Wilson LC, Eling TE (2002) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcino-genesis 23:425-434 (Pubitemid 34257622)
28. Baek SJ, Horowitz JM, Eling TE (2001) Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J Biol Chem 276:33384-33392
29. Hsiao EC, Koniaris LG, Zimmers-Koniaris T et al (2000) Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 20:3742-3751 (Pubitemid 30243919)
30. Schlittenhardt D, Schober A, Strelau J et al (2004) Involvement of growth differentiation factor-15/macrophage inhibitory cyto-kine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 318:325-333 (Pubitemid 39506502)
31. SugulleM,DechendR,Herse Fetal(2009) Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus. Hypertension 54:106-112
32. Lankeit M, Kempf T, Dellas C et al (2008) Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med 177:1018-1025 (Pubitemid 351717597)
33. Lajer M, Jorsal A, Tarnow L et al (2010) Plasma growth differentiation factor-15 (GDF-15) independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetes Care 33:1567-1572